Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Autoimmune Disorders

Free Subscription 01.01.2020 1 Acta Neurol Scand 1 Am J Kidney Dis 6 BMC Neurol 4 Diabetes 3 Diabetes Res Clin Pract 3 Intern Med 5 J Autoimmun 10 J Clin Endocrinol Metab 6 J Immunol 1 J Nephrol 4 J Neuroimmunol 6 J Neurol 6 J Pediatr Endocrinol Metab 1 Kidney Int 10 Mult Scler 2 N Engl J Med 20 Neurology 12 PLoS One 1 Proc Natl Acad Sci U S A 2 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Neurol Scand

1. SCOTT TF, Diehl D, Elmalik W, Gettings EJ, et al
   Multiple sclerosis relapses contribute to long-term disability.
   Acta Neurol Scand. 2019;140:336-341.
   PubMed     Text format     Abstract available
   
   

   
   Am J Kidney Dis

2. KOYE DN, Magliano DJ, Reid CM, Pavkov ME, et al
   Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
   Am J Kidney Dis. 2018 Dec 14. pii: S0272-6386(18)31085.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

3. JIN A, Mamelona J, Harper B, Marrero A, et al
   Recurrent post-partum rhombencephalitis associated with anti-centromere antibody: a case report.
   BMC Neurol. 2019;19:235.
   PubMed     Text format     Abstract available
   
   
4. KAWACHI I, Okamoto S, Sakamoto M, Ohta H, et al
   Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database.
   BMC Neurol. 2019;19:324.
   PubMed     Text format     Abstract available
   
   
5. BACCI ED, Coyne KS, Poon JL, Harris L, et al
   Understanding side effects of therapy for myasthenia gravis and their impact on daily life.
   BMC Neurol. 2019;19:335.
   PubMed     Text format     Abstract available
   
   
6. IMANI D, Razi B, Motallebnezhad M, Rezaei R, et al
   Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis.
   BMC Neurol. 2019;19:339.
   PubMed     Text format     Abstract available
   
   
7. CHEN H, Li X, Zhang X, Xu W, et al
   Late delayed radiation-induced cerebral Arteriopathy by high-resolution magnetic resonance imaging: a case report.
   BMC Neurol. 2019;19:232.
   PubMed     Text format     Abstract available
   
   
8. DEEB K, Eby J, Labault-Santiago J
   Demyelinating syndrome in systemic sclerosis and neuromyelitis optica.
   BMC Neurol. 2019;19:234.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes

9. 
   In This Issue of Diabetes.
   Diabetes. 2019;68:1097-1098.
   PubMed     Text format    
   
   
10. HALLER MJ, Long SA, Blanchfield JL, Schatz DA, et al
    Low-dose Anti-Thymocyte Globulin Preserves C-Peptide and Reduces A1c in New Onset Type 1 Diabetes: Two Year Clinical Trial Data.
    Diabetes. 2019 Apr 9. pii: db19-0057. doi: 10.2337/db19-0057.
    PubMed     Text format     Abstract available
    
    
11. HABIB T, Long SA, Samuels PL, Brahmandam A, et al
    Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.
    Diabetes. 2019;68:1240-1250.
    PubMed     Text format     Abstract available
    
    
12. ZOBEL EH, Hasbak P, Winther SA, Stevns C, et al
    Cardiac Autonomic Function is Associated With Myocardial Flow Reserve in Type 1 Diabetes.
    Diabetes. 2019 Mar 12. pii: db18-1313. doi: 10.2337/db18-1313.
    PubMed     Text format     Abstract available
    
    

    
    Diabetes Res Clin Pract

13. AHOLA AJ, Forsblom C, Harjutsalo V, Groop PH, et al
    Dietary intake in type 1 diabetes at different stages of diabetic kidney disease.
    Diabetes Res Clin Pract. 2019;155:107775.
    PubMed     Text format     Abstract available
    
    
14. DI BONITO P, Mozzillo E, Esposito M, Rosanio FM, et al
    Non-albuminuric reduced eGFR phenotype in children and adolescents with type 1 diabetes.
    Diabetes Res Clin Pract. 2019;155:107781.
    PubMed     Text format     Abstract available
    
    
15. PIRIE FJ, Jairam V, Paruk IM, Connolly C, et al
    High frequency of hypoglycaemia in patients with type 1 diabetes mellitus attending a tertiary diabetes clinic in Durban, South Africa.
    Diabetes Res Clin Pract. 2019;155:107783.
    PubMed     Text format     Abstract available
    
    

    
    Intern Med

16. KAWAGUCHI T, Arinaga-Hino T, Shimizu M, Tanikawa K, et al
    Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate.
    Intern Med. 2019;58:2501-2505.
    PubMed     Text format     Abstract available
    
    
17. MAEDA R, Naito D, Adachi A, Shiraishi H, et al
    IgG4-related Disease Involving the Cardiovascular System: An Intracardiac Mass and a Mass Lesion Surrounding a Coronary Artery.
    Intern Med. 2019;58:2363-2366.
    PubMed     Text format     Abstract available
    
    
18. NISHIKAWA M, Shimada N, Kawazoe T, Sawaki R, et al
    A Case of Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura.
    Intern Med. 2019 Dec 20. doi: 10.2169/internalmedicine.3837.
    PubMed     Text format     Abstract available
    
    

    
    J Autoimmun

19. SCHEINECKER C, Goschl L, Bonelli M
    Treg cells in health and autoimmune diseases: New insights from single cell analysis.
    J Autoimmun. 2019 Dec 17:102376. doi: 10.1016/j.jaut.2019.102376.
    PubMed     Text format     Abstract available
    
    
20. MENG J, Liu X, Zhang P, Li D, et al
    Corrigendum to "Rb selectively inhibits innate IFN-beta production by enhancing deacetylation of IFN-beta promoter through HDAC1 and HDAC8" [J. Autoimmun. 73C (2016) 42-53].
    J Autoimmun. 2020;106:102380.
    PubMed     Text format    
    
    
21. HUANG C, Yi X, Long H, Zhang G, et al
    Disordered cutaneous microbiota in systemic lupus erythematosus.
    J Autoimmun. 2019 Dec 26:102391. doi: 10.1016/j.jaut.2019.102391.
    PubMed     Text format     Abstract available
    
    
22. WATANABE-KUSUNOKI K, Nakazawa D, Kusunoki Y, Kudo T, et al
    Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
    J Autoimmun. 2019 Dec 26:102390. doi: 10.1016/j.jaut.2019.102390.
    PubMed     Text format     Abstract available
    
    
23. SAFERDING V, Bluml S
    Innate immunity as the trigger of systemic autoimmune diseases.
    J Autoimmun. 2019 Dec 26:102382. doi: 10.1016/j.jaut.2019.102382.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Endocrinol Metab

24. NAPIER C, Gan EH, Mitchell AL, Gilligan LC, et al
    Residual Adrenal Function in Autoimmune Addison's Disease - Effect of Dual Therapy with Rituximab and Depot Tetracosactide.
    J Clin Endocrinol Metab. 2019 Dec 21. pii: 5682802. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
25. FALLAHI P, Ferrari SM, Ragusa F, Ruffilli I, et al
    Th1 chemokines in autoimmune endocrine disorders.
    J Clin Endocrinol Metab. 2019 Dec 21. pii: 5683662. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
26. KAHALY GJ, Diana T, Kanitz M, Frommer L, et al
    Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves' Disease.
    J Clin Endocrinol Metab. 2019 Dec 22. pii: 5684882. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
27. REDONDO MJ, Sosenko J, Libman I, McVean JJF, et al
    Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated with Older Age and Insulin Resistance.
    J Clin Endocrinol Metab. 2019 Dec 23. pii: 5684911. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
28. ROELS S, Costa OR, Tersey SA, Stange G, et al
    Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D.
    J Clin Endocrinol Metab. 2019;104:451-460.
    PubMed     Text format     Abstract available
    
    
29. SCOTT SN, Cocks M, Andrews RC, Narendran P, et al
    Hit Improves Aerobic Capacity Without a Detrimental Decline in Blood Glucose in People with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2018 Oct 2. pii: 5110608. doi: 10.1210/jc.2018-01309.
    PubMed     Text format     Abstract available
    
    
30. COLOMBO C, De Leo S, Di Stefano M, Vannucchi G, et al
    Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
    J Clin Endocrinol Metab. 2019;104:779-784.
    PubMed     Text format     Abstract available
    
    
31. YARDLEY JE, Rees JL, Funk DR, Toghi-Eshghi SR, et al
    Effects of Moderate Cycling Exercise on Blood Glucose Regulation Following Successful Clinical Islet Transplantation.
    J Clin Endocrinol Metab. 2019;104:493-502.
    PubMed     Text format     Abstract available
    
    
32. SMITH TJ
    Potential roles of CD34+ fibrocytes masquerading as orbital fibroblasts in thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2018 Nov 15. pii: 5183248. doi: 10.1210/jc.2018-01493.
    PubMed     Text format     Abstract available
    
    
33. WARNCKE K, Kummer S, Raile K, Grulich-Henn J, et al
    Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.
    J Clin Endocrinol Metab. 2019;104:845-855.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

34. YOSHIMURA S, Thome R, Konno S, Mari ER, et al
    IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
    J Immunol. 2019 Dec 18. pii: jimmunol.1801113. doi: 10.4049/jimmunol.1801113.
    PubMed     Text format     Abstract available
    
    
35. WAN X, Pei W, Shahzad KA, Zhang L, et al
    Correction: A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4(+) and CD8(+) T Cells.
    J Immunol. 2019 Dec 23. pii: jimmunol.1901408. doi: 10.4049/jimmunol.1901408.
    PubMed     Text format    
    
    
36. KOERS J, Derksen NIL, Ooijevaar-de Heer P, Nota B, et al
    Biased N-Glycosylation Site Distribution and Acquisition across the Antibody V Region during B Cell Maturation.
    J Immunol. 2019;202:2220-2228.
    PubMed     Text format     Abstract available
    
    
37. CHU T, Ni M, Chen C, Akilesh S, et al
    Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells.
    J Immunol. 2019;202:2529-2534.
    PubMed     Text format     Abstract available
    
    
38. BOXBERGER N, Hecker M, Zettl UK
    Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases.
    J Immunol. 2019;202:2177-2187.
    PubMed     Text format     Abstract available
    
    
39. BUDZINSKI L, Schulz AR, Baumgart S, Burns T, et al
    Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry.
    J Immunol. 2019;202:3103-3112.
    PubMed     Text format     Abstract available
    
    

    
    J Nephrol

40. XU BY, Meng SJ, Shi SF, Liu LJ, et al
    MicroRNA-21-5p participates in IgA nephropathy by driving T helper cell polarization.
    J Nephrol. 2019 Dec 20. pii: 10.1007/s40620-019-00682.
    PubMed     Text format     Abstract available
    
    

    
    J Neuroimmunol

41. UZAWA A, Ozawa Y, Yasuda M, Oda F, et al
    Increased serum acetylcholine receptor alpha1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis.
    J Neuroimmunol. 2019;339:577125.
    PubMed     Text format     Abstract available
    
    
42. LAZARIDIS K, Baltatzidou V, Tektonidis N, Tzartos SJ, et al
    Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis.
    J Neuroimmunol. 2019;339:577136.
    PubMed     Text format     Abstract available
    
    
43. JOOB B, Wiwanitkit V
    Tumor necrosis factor alpha -863C/A polymorphism and Guillain-Barre Syndrome.
    J Neuroimmunol. 2019;339:577140.
    PubMed     Text format    
    
    
44. SHIMASAKI C, Frye RE, Trifiletti R, Cooperstock M, et al
    Evaluation of the Cunningham Panel in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes
    J Neuroimmunol. 2019;339:577138.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

45. HEDSTROM AK, Olsson T, Kockum I, Hillert J, et al
    Low sun exposure increases multiple sclerosis risk both directly and indirectly.
    J Neurol. 2019 Dec 17. pii: 10.1007/s00415-019-09677.
    PubMed     Text format     Abstract available
    
    
46. NESS NH, Schriefer D, Haase R, Ettle B, et al
    Differentiating societal costs of disability worsening in multiple sclerosis.
    J Neurol. 2019 Dec 17. pii: 10.1007/s00415-019-09676.
    PubMed     Text format     Abstract available
    
    
47. SCHUSTER S, Ozga AK, Stellmann JP, Deb-Chatterji M, et al
    Relapse rates and long-term outcome in primary angiitis of the central nervous system.
    J Neurol. 2019;266:1481-1489.
    PubMed     Text format     Abstract available
    
    
48. KOGA M, Kishi M, Fukusako T, Ikuta N, et al
    Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics.
    J Neurol. 2019;266:1655-1662.
    PubMed     Text format     Abstract available
    
    
49. TANI H, Nagai K, Hosokawa T, Hata K, et al
    Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis.
    J Neurol. 2019;266:1708-1715.
    PubMed     Text format     Abstract available
    
    
50. AYRIGNAC X, Rigau V, Lhermitte B, Vincent T, et al
    Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.
    J Neurol. 2019;266:1743-1755.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Endocrinol Metab

51. ASL SN, Vakili R, Vakili S, Soheilipour F, et al
    Wolcott-Rallison syndrome in Iran: a common cause of neonatal diabetes.
    J Pediatr Endocrinol Metab. 2019;32:607-613.
    PubMed     Text format     Abstract available
    
    
52. WIJAYA M, Huamei M, Jun Z, Du M, et al
    Etiology of primary adrenal insufficiency in children: a 29-year single-center experience.
    J Pediatr Endocrinol Metab. 2019;32:615-622.
    PubMed     Text format     Abstract available
    
    
53. SEVALIEV N, Strich D, Avnon-Ziv C, Levy-Khademi F, et al
    The metabolic consequences of overweight in a cohort of children with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2019;32:715-719.
    PubMed     Text format     Abstract available
    
    
54. VENTURA M, Serra-Caetano J, Cardoso R, Dinis I, et al
    The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience.
    J Pediatr Endocrinol Metab. 2019;32:721-726.
    PubMed     Text format     Abstract available
    
    
55. ZHANG Y, Zhang H, Li P
    Cardiovascular risk factors in children with type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2019;32:699-705.
    PubMed     Text format     Abstract available
    
    
56. SINGER-GRANICK C, Liu JK, Bleich D, Cespedes L, et al
    Diagnosis of cyclic Cushing's disease manifests as early morning hyperglycemia in a patient with previously well-controlled type 1 diabetes.
    J Pediatr Endocrinol Metab. 2019;32:785-789.
    PubMed     Text format     Abstract available
    
    

    
    Kidney Int

57. BREITKOPF DM, Jankowski V, Ohl K, Hermann J, et al
    The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus.
    Kidney Int. 2019 Oct 30. pii: S0085-2538(19)31039.
    PubMed     Text format     Abstract available
    
    

    
    Mult Scler

58. KALKERS NF, Galan I, Kerbrat A, Tacchino A, et al
    Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries.
    Mult Scler. 2019 Dec 17:1352458519895450. doi: 10.1177/1352458519895450.
    PubMed     Text format     Abstract available
    
    
59. COULOUME L, Barbin L, Leray E, Wiertlewski S, et al
    High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice.
    Mult Scler. 2019 Dec 17:1352458519894713. doi: 10.1177/1352458519894713.
    PubMed     Text format     Abstract available
    
    
60. CROUSE DL, Foroughi I, Gupta N
    Neighbourhood environments and the risk of hospital admission for cardiometabolic and mental health comorbidities in multiple sclerosis: A population cohort analysis using linked administrative data.
    Mult Scler. 2019 Dec 20:1352458519895985. doi: 10.1177/1352458519895985.
    PubMed     Text format     Abstract available
    
    
61. BOVIS F, De Stefano N, Steinerman JR, Knappertz V, et al
    Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.
    Mult Scler. 2019;25:217-223.
    PubMed     Text format     Abstract available
    
    
62. BSTEH G, Hegen H, Ladstatter F, Berek K, et al
    Change of olfactory function as a marker of inflammatory activity and disability progression in MS.
    Mult Scler. 2019;25:267-274.
    PubMed     Text format     Abstract available
    
    
63. HEDSTROM AK
    Smoking and its interaction with genetics in MS etiology.
    Mult Scler. 2019;25:180-186.
    PubMed     Text format     Abstract available
    
    
64. BOVE R
    We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Commentary.
    Mult Scler. 2019;25:190-192.
    PubMed     Text format    
    
    
65. ALVAREZ E, Mowry EM
    We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes.
    Mult Scler. 2019;25:187-188.
    PubMed     Text format    
    
    
66. HELLWIG K
    We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - No.
    Mult Scler. 2019;25:189-190.
    PubMed     Text format    
    
    
67. BARANZINI SE
    Insights into microbiome research 5: Mapping is first but function must come next.
    Mult Scler. 2019;25:193-195.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

68. MORAND EF, Furie R, Tanaka Y, Bruce IN, et al
    Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
    N Engl J Med. 2019 Dec 18. doi: 10.1056/NEJMoa1912196.
    PubMed     Text format     Abstract available
    
    
69. YAMAMURA T, Kleiter I, Fujihara K, Palace J, et al
    Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:2114-2124.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

70. WAUBANT E, Gilmore W
    Mind the gap: Quantifying gender representation as a first step to solve the problem?
    Neurology. 2019;92:698-699.
    PubMed     Text format    
    
    
71. LAPUCCI C, Saitta L, Bommarito G, Sormani MP, et al
    How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
    Neurology. 2019 Mar 8. pii: WNL.0000000000007266.
    PubMed     Text format     Abstract available
    
    
72. JOHANSEN A, Christensen SJ, Scheie D, Hojgaard JLS, et al
    Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: Systematic review.
    Neurology. 2019;92:663-674.
    PubMed     Text format     Abstract available
    
    
73. MARRIE RA, Garland A, Schaffer SA, Fransoo R, et al
    Traditional risk factors may not explain increased incidence of myocardial infarction in MS.
    Neurology. 2019;92:e1624-e1633.
    PubMed     Text format     Abstract available
    
    
74. OH J, Ontaneda D, Azevedo C, Klawiter EC, et al
    Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.
    Neurology. 2019 Feb 20. pii: WNL.0000000000007099.
    PubMed     Text format     Abstract available
    
    
75. NG PS, Dyck PJ, Laughlin RS, Thapa P, et al
    Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.
    Neurology. 2019;92:e1188-e1194.
    PubMed     Text format     Abstract available
    
    
76. WATERS PJ, Komorowski L, Woodhall M, Lederer S, et al
    A multicenter comparison of MOG-IgG cell-based assays.
    Neurology. 2019;92:e1250-e1255.
    PubMed     Text format     Abstract available
    
    
77. MATTOZZI S, Sabater L, Escudero D, Arino H, et al
    Hashimoto encephalopathy in the 21st century.
    Neurology. 2019 Dec 27. pii: WNL.0000000000008785.
    PubMed     Text format     Abstract available
    
    
78. TYLER KL, Ruegg S
    The neuromythology of Hashimoto encephalopathy: The emperor has no clothes.
    Neurology. 2019 Dec 27. pii: WNL.0000000000008776.
    PubMed     Text format    
    
    
79. KILLESTEIN J, Reder AT
    Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring.
    Neurology. 2019;92:696-697.
    PubMed     Text format    
    
    
80. MEHTA D, Miller C, Arnold DL, Bame E, et al
    Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.
    Neurology. 2019;92:e1724-e1738.
    PubMed     Text format     Abstract available
    
    
81. DI LUCA DG, Landman J, Ortega MR, Gultekin SH, et al
    Clinical Reasoning: A 47-year-old man with diffuse white matter disease and rapidly progressive dementia.
    Neurology. 2019;92:e2832-e2837.
    PubMed     Text format    
    
    
82. WAUBANT E, Banwell B, Wassmer E, Sormani MP, et al
    Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.
    Neurology. 2019;92:e2538-e2549.
    PubMed     Text format     Abstract available
    
    
83. DI LUCA DG, De Leon-Benedetti A, Williamson S, Irving LT, et al
    Teaching Video NeuroImages: A patient with Holmes tremor due to demyelinating lesion of the inferior cerebellar peduncle.
    Neurology. 2019;92:e2179-e2180.
    PubMed     Text format    
    
    
84. LANNUZEL A, Ferge JL, Lobjois Q, Signate A, et al
    Long-term outcome in neuroZika: When biological diagnosis matters.
    Neurology. 2019;92:e2406-e2420.
    PubMed     Text format     Abstract available
    
    
85. MAMMELE S, Thompson KS, Abe KK
    A rapidly fatal case of anti-NMDA receptor encephalitis due to acute brain edema and herniation.
    Neurology. 2019;92:1014-1016.
    PubMed     Text format    
    
    
86. ZHANG C, Wang SG, Wang Y, Liu XL, et al
    Teaching Video NeuroImages: Cautious walking gait in siblings with hereditary hyperekplexia.
    Neurology. 2019;92:e2068-e2069.
    PubMed     Text format    
    
    
87. DE BRUIJN MAAM, van Sonderen A, van Coevorden-Hameete MH, Bastiaansen AEM, et al
    Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis.
    Neurology. 2019;92:e2185-e2196.
    PubMed     Text format     Abstract available
    
    
88. PAPADOPOULOU A, Gaetano L, Pfister A, Altermatt A, et al
    Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.
    Neurology. 2019;92:e2240-e2249.
    PubMed     Text format     Abstract available
    
    
89. BLANKENBACH K, Schwab N, Hofner B, Adams O, et al
    Natalizumab-associated progressive multifocal leukoencephalopathy in Germany.
    Neurology. 2019;92:e2232-e2239.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

90. KAGEYAMA T, Furuta S, Ikeda K, Kagami SI, et al
    Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases.
    PLoS One. 2019;14:e0214324.
    PubMed     Text format     Abstract available
    
    
91. LEE J, An JN, Hwang JH, Lee H, et al
    p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients.
    PLoS One. 2019;14:e0213981.
    PubMed     Text format     Abstract available
    
    
92. SHIRIN A, Della Rossa F, Klickstein I, Russell J, et al
    Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon.
    PLoS One. 2019;14:e0213665.
    PubMed     Text format     Abstract available
    
    
93. LARDINOIS OM, Deterding LJ, Hess JJ, Poulton CJ, et al
    Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
    PLoS One. 2019;14:e0213215.
    PubMed     Text format     Abstract available
    
    
94. NEATE SL, Taylor KL, Jelinek GA, De Livera AM, et al
    Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification.
    PLoS One. 2019;14:e0212422.
    PubMed     Text format     Abstract available
    
    
95. LEE SU, Li CF, Mortales CL, Pawling J, et al
    Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.
    PLoS One. 2019;14:e0214253.
    PubMed     Text format     Abstract available
    
    
96. BAGCHI S, Lingaiah R, Mani K, Barwad A, et al
    Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    PLoS One. 2019;14:e0214256.
    PubMed     Text format     Abstract available
    
    
97. ATKINSON MA, Joo S, Sule S
    Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.
    PLoS One. 2019;14:e0214248.
    PubMed     Text format     Abstract available
    
    
98. KAIHAN AB, Yasuda Y, Imaizumi T, Inagaki K, et al
    Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.
    PLoS One. 2019;14:e0214414.
    PubMed     Text format     Abstract available
    
    
99. AZAMI M, YektaKooshali MH, Shohani M, Khorshidi A, et al
    Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0214738.
    PubMed     Text format     Abstract available
    
    
100. VAZQUEZ-MATEO C, Collins J, Goldberg SJ, Lawson M, et al
     Combining anti-IL-7Ralpha antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
     PLoS One. 2019;14:e0214379.
     PubMed     Text format     Abstract available
     
     
101. GAVILAN-CARRERA B, Garcia da Silva J, Vargas-Hitos JA, Sabio JM, et al
     Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity.
     PLoS One. 2019;14:e0212436.
     PubMed     Text format     Abstract available
     
     

     
     Proc Natl Acad Sci U S A

102. GOURH P, Safran SA, Alexander T, Boyden SE, et al
     HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.
     Proc Natl Acad Sci U S A. 2019 Dec 23. pii: 1906593116.
     PubMed     Text format     Abstract available
     
     

     
     Thyroid

103. VANNUCCHI G, Covelli D, Campi I, Curro N, et al
     Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
     Thyroid. 2019;29:1828-1833.
     PubMed     Text format     Abstract available
     
     
104. LI Y, Wang X, Liu Z, Ma J, et al
     Hashimoto's Thyroiditis with Increased IgG4-positive Plasma Cells: Using Thyroid-specific Diagnostic Criteria May Identify Early-Phase IgG4 Thyroiditis.
     Thyroid. 2019 Dec 20. doi: 10.1089/thy.2019.0063.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: